Skip to main content
Product Development in Quality Management Systems

Product Development in Quality Management Systems

$249.00
Your guarantee:
30-day money-back guarantee — no questions asked
How you learn:
Self-paced • Lifetime updates
When you get access:
Course access is prepared after purchase and delivered via email
Toolkit Included:
Includes a practical, ready-to-use toolkit containing implementation templates, worksheets, checklists, and decision-support materials used to accelerate real-world application and reduce setup time.
Who trusts this:
Trusted by professionals in 160+ countries
Adding to cart… The item has been added

This curriculum spans the full product development lifecycle within regulated environments, comparable to the structured workflows of a multi-phase medical device submission program, integrating design controls, risk management, and cross-functional coordination required in actual quality-managed development projects.

Module 1: Integrating Quality by Design into Product Development

  • Selecting and applying FMEA (Failure Modes and Effects Analysis) during concept development to prioritize design risks based on severity, occurrence, and detection.
  • Defining critical-to-quality (CTQ) characteristics in collaboration with cross-functional teams and translating them into measurable design inputs.
  • Establishing design verification protocols that align with regulatory requirements (e.g., FDA 21 CFR Part 820, ISO 13485) while ensuring statistical validity of test sample sizes.
  • Documenting design history files (DHF) with version-controlled records of design reviews, outputs, and changes to support audit readiness.
  • Implementing stage-gate reviews with predefined quality checkpoints to assess design maturity before advancing to the next development phase.
  • Choosing between concurrent engineering and phased development approaches based on product complexity and regulatory classification.

Module 2: Regulatory Strategy and Compliance Planning

  • Mapping product classification (e.g., Class I, II, III under FDA or MDR Rule-based classification) to determine applicable regulatory pathways and conformity assessment procedures.
  • Developing a regulatory submission timeline that accounts for Notified Body review cycles, premarket notification (510(k)), or PMA requirements.
  • Coordinating with regulatory affairs to ensure design outputs meet essential requirements in directives such as EU MDR or IVDR.
  • Conducting gap analyses between current design controls and target market regulations to prioritize compliance activities.
  • Establishing a global regulatory intelligence process to monitor changes in standards (e.g., ISO 14971 updates) and adapt design plans accordingly.
  • Designing labeling and UDI implementation plans that satisfy jurisdiction-specific requirements while maintaining consistency across markets.

Module 3: Risk Management Throughout the Product Lifecycle

  • Updating risk management files (RMF) iteratively as new design data, usability studies, or post-market feedback becomes available.
  • Justifying risk acceptance decisions through documented rationale, including residual risk evaluation and benefit-risk analysis.
  • Integrating human factors engineering outputs into risk assessments to address use-related hazards in device design.
  • Linking risk control measures directly to design outputs and verification tests to ensure traceability from hazard to mitigation.
  • Conducting post-production risk reviews using field complaints, service reports, and CAPA data to validate initial risk assumptions.
  • Managing risk documentation in a configuration-managed system to maintain alignment with product versions and design changes.

Module 4: Design Verification and Validation Execution

  • Developing statistically justified test plans for design verification, including selection of appropriate methods (e.g., t-tests, ANOVA, reliability modeling).
  • Specifying pass/fail criteria in test protocols based on performance requirements and clinical relevance, not arbitrary tolerances.
  • Managing outsourced testing activities by defining vendor responsibilities, data ownership, and audit rights in service agreements.
  • Executing design validation under simulated or actual use conditions with representative users to confirm intended use fulfillment.
  • Addressing out-of-specification test results through deviation investigations and impact assessments on product safety and effectiveness.
  • Ensuring test environments replicate intended use conditions, including environmental stressors (e.g., temperature, humidity) for robustness testing.

Module 5: Supplier and Outsourced Development Oversight

  • Classifying suppliers based on risk (e.g., critical, key, standard) to determine audit frequency, qualification requirements, and monitoring intensity.
  • Negotiating technical agreements that define quality responsibilities, data rights, change control processes, and access for audits.
  • Validating supplier processes (e.g., injection molding, sterilization) when their output cannot be fully verified by incoming inspection.
  • Managing design transfers to contract manufacturers by establishing clear design output specifications and acceptance criteria.
  • Tracking supplier nonconformances and linking them to internal CAPA systems to identify systemic quality trends.
  • Controlling supplier-driven design changes through a formal change evaluation process that includes impact assessment on risk and compliance.

Module 6: Change Management and Design Control Maintenance

  • Evaluating engineering change requests (ECRs) for impact on product performance, risk profile, and regulatory status before approval.
  • Executing design changes under a controlled change order system with documented justification, review, and approval trails.
  • Determining whether a design change requires new regulatory submissions based on significance and jurisdictional rules.
  • Maintaining traceability between design changes, updated risk assessments, verification testing, and DHF updates.
  • Coordinating change implementation across manufacturing, labeling, and service documentation to prevent configuration drift.
  • Managing legacy product changes by balancing obsolescence risks, component availability, and regulatory expectations for continued compliance.

Module 7: Post-Market Feedback Integration and Continuous Improvement

  • Establishing systematic processes to collect and analyze post-market data from complaints, service reports, and customer feedback.
  • Linking field issues to design inputs and risk management files to determine if root causes are design-related.
  • Initiating design improvements based on trended post-market data, even when issues fall within acceptable risk thresholds.
  • Updating design verification documentation when post-market findings reveal unanticipated use conditions or failure modes.
  • Coordinating with pharmacovigilance or incident reporting teams to ensure timely submission of field safety corrective actions (FSCAs).
  • Using usability feedback from the field to inform next-generation product design and usability validation protocols.

Module 8: Cross-Functional Governance and Quality System Alignment

  • Defining roles and responsibilities for design inputs, reviews, and approvals in a RACI matrix across engineering, QA, regulatory, and clinical teams.
  • Integrating design control activities into the organization’s quality management system (QMS) with documented procedures and workflows.
  • Conducting internal audits of design processes to verify compliance with ISO 13485 or 21 CFR 820 requirements.
  • Aligning product development timelines with management review cycles to report on design progress, risks, and quality metrics.
  • Managing resource allocation for quality activities (e.g., testing, documentation) without compromising development deadlines.
  • Resolving conflicts between innovation goals and quality constraints through documented risk-based decision-making protocols.
!